Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist was written by Zheng, Yajun;Zhuang, Linghang;Fan, Kristi Yi;Tice, Colin M.;Zhao, Wei;Dong, Chengguo;Lotesta, Stephen D.;Leftheris, Katerina;Lindblom, Peter R.;Liu, Zhijie;Shimada, Jun;Noto, Paul B.;Meng, Shi;Hardy, Andrew;Howard, Lamont;Krosky, Paula;Guo, Joan;Lipinski, Kerri;Kandpal, Geeta;Bukhtiyarov, Yuri;Zhao, Yi;Lala, Deepak;Van Orden, Rebecca;Zhou, Jing;Chen, Guozhou;Wu, Zhongren;McKeever, Brian M.;McGeehan, Gerard M.;Gregg, Richard E.;Claremon, David A.;Singh, Suresh B.. And the article was included in Journal of Medicinal Chemistry in 2016.Name: Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate This article mentions the following:
This article describes the application of Contour to the design and discovery of a novel, potent, orally efficacious liver X receptor β (LXRβ) agonist ((R)-(2-(4-(4-(hydroxymethyl)-3-(methylsulfonyl)phenyl)-2-isopropylpiperazin-1-yl)-4-(trifluoromethyl)pyrimidin-5-yl)methanol (17)). Contour technol. is a structure-based drug design platform that generates mols. using a context perceptive growth algorithm guided by a contact sensitive scoring function. The growth engine uses binding site perception and programmable growth capability to create drug-like mols. by assembling fragments that naturally complement hydrophilic and hydrophobic features of the protein binding site. Starting with a crystal structure of LXRβ and a docked 2-(methylsulfonyl)benzyl alc. fragment, Contour was used to design agonists containing a piperazine core. Compound (17) binds to LXRβ with high affinity and to LXRα to a lesser extent, and induces the expression of LXR target genes in vitro and in vivo. This mol. served as a starting point for further optimization and generation of a candidate which is currently in human clin. trials for treating atopic dermatitis. In the experiment, the researchers used many compounds, for example, Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate (cas: 187035-79-6Name: Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate).
Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate (cas: 187035-79-6) belongs to pyrimidine derivatives. Heterocyclic compounds bearing the pyrimidine core are of tremendous interest as they constitute an important class of natural and synthetic compounds exhibiting diverse useful biological activities that hold attractive potential for clinical translation as therapeutic agents in alleviation of a myriad of diseases. For example, the neurotoxin tetrodotoxin is a pyrimidine derivative. It is found in a number of species including the Japanese puffer fish, the blue-ringed octopus, and the orange-bellied newt. Tetrodotoxin prevents the transmission of nerve signals and can result in paralysis and death.Name: Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate
Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia